Dongwha Pharm.Co.,Ltd (KRX: 000020)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,290.00
-80.00 (-1.26%)
Dec 20, 2024, 3:30 PM KST

Dongwha Pharm.Co.,Ltd Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
174,346284,265256,309404,115542,492229,420
Upgrade
Market Cap Growth
-20.71%10.91%-36.58%-25.51%136.46%-8.68%
Upgrade
Enterprise Value
240,781195,948161,993319,081430,132137,035
Upgrade
Last Close Price
6290.0010270.009092.6514067.6218698.447831.27
Upgrade
PE Ratio
22.7210.3612.5722.6119.0325.17
Upgrade
PS Ratio
0.410.790.751.381.990.75
Upgrade
PB Ratio
0.460.700.671.121.580.77
Upgrade
P/TBV Ratio
0.740.900.741.231.730.78
Upgrade
P/FCF Ratio
-61.4523.7528.6930.1727.03
Upgrade
P/OCF Ratio
-9.758.7711.2210.3917.27
Upgrade
EV/Sales Ratio
0.560.540.481.091.580.45
Upgrade
EV/EBITDA Ratio
8.786.023.829.2212.736.53
Upgrade
EV/EBIT Ratio
26.6310.505.4214.1818.6414.40
Upgrade
EV/FCF Ratio
-5.8142.3615.0122.6523.9216.15
Upgrade
Debt / Equity Ratio
0.190.120.020.030.050.02
Upgrade
Debt / EBITDA Ratio
2.801.450.160.330.460.33
Upgrade
Debt / FCF Ratio
-10.180.620.810.870.81
Upgrade
Asset Turnover
0.800.700.750.660.670.82
Upgrade
Inventory Turnover
3.362.913.843.793.664.81
Upgrade
Quick Ratio
1.151.552.342.802.743.59
Upgrade
Current Ratio
2.022.263.063.373.364.23
Upgrade
Return on Equity (ROE)
1.37%7.17%5.83%5.55%8.92%3.05%
Upgrade
Return on Assets (ROA)
1.03%2.27%4.11%3.19%3.56%1.59%
Upgrade
Return on Capital (ROIC)
1.25%2.77%4.92%3.84%4.33%1.97%
Upgrade
Earnings Yield
4.40%9.65%7.95%4.42%5.25%3.97%
Upgrade
FCF Yield
-23.77%1.63%4.21%3.49%3.31%3.70%
Upgrade
Dividend Yield
2.86%1.75%1.98%1.28%0.96%-
Upgrade
Payout Ratio
65.03%18.16%24.44%27.81%11.62%36.34%
Upgrade
Buyback Yield / Dilution
-0.13%-0.02%-0.16%-0.05%-0.05%-
Upgrade
Total Shareholder Return
2.73%1.73%1.82%1.23%0.91%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.